← Leaderboards
Francesco Angelucci
University Of Illinois At Chicago
$671,596
Attributed
$2,014,787
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $800.6K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,014,787 · 2
By mechanism
R01$1,567,644 · 1
R21$447,143 · 1
Top collaborators
- Pavel A Petukhov4 shared
- David Lee Williams4 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Pavel A Petukhov$5,330,073
- Clifton David Fuller$6,957,707
- Neelima B Chauhan$1,494,977
- Susan Magasi$1,807,097
Others in their field
Other Emerging Leaders on “Metabolic”
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Barbara Halina Braffett · George Washington University$22,016,904
- Ionut Bebu · George Washington University$18,816,779
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,459,738
- Rainer Lohmann · University Of Rhode Island$14,400,221
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
Research focus
MetabolicLethal Dose 50Drug MetabolismInfectionIn VitroLeadDrug DevelopmentDrug KineticsEnzymesEvolutionAdultBiological AvailabilityCellsCessation Of LifeAdolescentDesignChronic DiseaseDrug DiscoveryAnimal ModelDrug ResistanceBiochemicalComputer AssistedBiochemistryMolecular
Grant awards (4)
Development of novel TGR inhibitors for the treatment of schistosomiasis$767,020
R01 · FY2025 · AI
Development of novel TGR inhibitors for the treatment of schistosomiasis$800,624
R01 · FY2024 · AI
Discovery of novel smHDAC8 inhibitors for the treatment of schistosomiasis$230,492
R21 · FY2022 · AI
Discovery of novel smHDAC8 inhibitors for the treatment of schistosomiasis$216,651
R21 · FY2021 · AI